SEC Form 4 · accession 0001209191-18-047214
Xencor Inc · XNCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul A Foster
Officer — Chief Medical Officer
Period of report
Aug 14, 2018
Accepted (ET)
Aug 16, 2018 · 7:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326732
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 14, 2018 | M | 15,496 | $11.05 | A | 20,448 | D | |
| Common StockF2 | Aug 14, 2018 | S | 15,496 | $41.1061 | D | 4,952 | D | |
| Common Stock | Aug 15, 2018 | M | 106 | $11.05 | A | 5,058 | D | |
| Common Stock | Aug 15, 2018 | S | 106 | $41.10 | D | 4,952 | D | |
| Common Stock | Aug 16, 2018 | M | 20,739 | $11.05 | A | 25,691 | D | |
| Common Stock | Aug 16, 2018 | S | 20,739 | $41.10 | D | 4,952 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $11.05 | Aug 14, 2018 | M | 15,496 | D | — | Feb 20, 2024 | Common Stock | 15,496 | 74,504 | D |
| Stock Option (right to buy)F3 | $11.05 | Aug 15, 2018 | M | 106 | D | — | Feb 20, 2024 | Common Stock | 106 | 74,398 | D |
| Stock Option (right to buy)F3 | $11.05 | Aug 16, 2018 | M | 20,739 | D | — | Feb 20, 2024 | Common Stock | 20,739 | 53,659 | D |
Explanation of responses
- F1Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 1,207 shares of Common Stock acquired on June 10, 2015, 1,212 shares of Common Stock acquired on December 10, 2015 and 114 shares of Common Stock acquired on June 9, 2018.
- F2The weighted average sale price for the transaction reported was $41.1061, and the range of prices were between $41.10 and $41.120. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F3The stock option is fully vested.